BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28960745)

  • 1. Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafe.
    Mason S; Osborn JS; Dhar R; Tonkin A; Ethington JD; Le V; Benuzillo J; Lappe DL; Knowlton KU; Bunch TJ; Anderson JL
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1468-1474. PubMed ID: 28960745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thoracic versus nonthoracic MR imaging for patients with an MR nonconditional cardiac implantable electronic device.
    Nyotowidjojo IS; Skinner K; Shah AS; Bisla J; Singh S; Khoubyari R; Ott P; Kalb B; Indik JH
    Pacing Clin Electrophysiol; 2018 Jun; 41(6):589-596. PubMed ID: 29603272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator.
    Russo RJ; Costa HS; Silva PD; Anderson JL; Arshad A; Biederman RW; Boyle NG; Frabizzio JV; Birgersdotter-Green U; Higgins SL; Lampert R; Machado CE; Martin ET; Rivard AL; Rubenstein JC; Schaerf RH; Schwartz JD; Shah DJ; Tomassoni GF; Tominaga GT; Tonkin AE; Uretsky S; Wolff SD
    N Engl J Med; 2017 Feb; 376(8):755-764. PubMed ID: 28225684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry.
    Russo RJ
    Am Heart J; 2013 Mar; 165(3):266-72. PubMed ID: 23453091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provision of MR imaging for patients with cardiac implantable electronic devices (CIEDs): a single-center experience and national survey.
    Murray AS; Gilligan PJ; Bisset JM; Nolan C; Galvin JM; Murray JG
    Ir J Med Sci; 2019 Aug; 188(3):999-1004. PubMed ID: 30368645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging in non-conditional pacemakers and implantable cardioverter-defibrillators: a systematic review and meta-analysis.
    Munawar DA; Chan JEZ; Emami M; Kadhim K; Khokhar K; O'Shea C; Iwai S; Pitman B; Linz D; Munawar M; Roberts-Thomson K; Young GD; Mahajan R; Sanders P; Lau DH
    Europace; 2020 Feb; 22(2):288-298. PubMed ID: 31995177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3 Tesla magnetic resonance imaging in patients with cardiac implantable electronic devices: a single centre experience.
    Fluschnik N; Tahir E; Erley J; Müllerleile K; Metzner A; Wenzel JP; Guerreiro H; Adam G; Blankenberg S; Kirchhof P; Tönnis T; Nikorowitsch J
    Europace; 2023 Feb; 25(2):571-577. PubMed ID: 36413601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Safety of Cardiac and Thoracic Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices.
    Dandamudi S; Collins JD; Carr JC; Mongkolwat P; Rahsepar AA; Tomson TT; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP
    Acad Radiol; 2016 Dec; 23(12):1498-1505. PubMed ID: 27717762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices.
    Do DH; Eyvazian V; Bayoneta AJ; Hu P; Finn JP; Bradfield JS; Shivkumar K; Boyle NG
    Heart Rhythm; 2018 Feb; 15(2):218-225. PubMed ID: 29017930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Performance of Magnetic Resonance Imaging Conditional and Nonconditional Cardiac Implantable Electronic Devices.
    Shah AD; Patel AU; Knezevic A; Hoskins MH; Hirsh DS; Merchant FM; El Chami MF; Delurgio DB; Patel AM; Leon AR; Langberg JJ; Lloyd MS
    Pacing Clin Electrophysiol; 2017 May; 40(5):467-475. PubMed ID: 28224629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not all pacemakers are created equal: MRI conditional pacemaker and lead technology.
    Ahmed FZ; Morris GM; Allen S; Khattar R; Mamas M; Zaidi A
    J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1059-65. PubMed ID: 24016320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical safety of an MRI conditional implantable cardioverter defibrillator system: A prospective Monocenter ICD-Magnetic resonance Imaging feasibility study (MIMI).
    Kypta A; Blessberger H; Hoenig S; Saleh K; Lambert T; Kammler J; Fellner F; Lichtenauer M; Steinwender C
    J Magn Reson Imaging; 2016 Mar; 43(3):574-84. PubMed ID: 26335332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of magnetic resonance imaging in patients with cardiac implantable electronic devices with generator and lead(s) brand mismatch.
    Minaskeian N; Hajnal SP; Liu MB; Klooster LM; Devick KL; Schwartz L; Jokerst CE; Sorajja D; Scott LR
    J Appl Clin Med Phys; 2022 Mar; 23(3):e13520. PubMed ID: 35066975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.
    Cohen JD; Costa HS; Russo RJ
    Am J Cardiol; 2012 Dec; 110(11):1631-6. PubMed ID: 22921995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter retrospective evaluation of magnetic resonance imaging in pediatric and congenital heart disease patients with cardiac implantable electronic devices.
    Gakenheimer-Smith L; Ou Z; Kuang J; Moore JP; Burrows A; Kovach J; Dechert B; Beach CM; Ayers M; Tan RB; Mostafavifar M; Mah DY; Conner TM; Turpin S; Avasarala K; Shah MJ; Webster G; Posey J; Etheridge SP; Binka E; Niu M; Asaki SY; Lambert LM; Pilcher TA
    Heart Rhythm; 2023 Dec; 20(12):1752-1758. PubMed ID: 37648183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Bailey WM; Mazur A; McCotter C; Woodard PK; Rosenthal L; Johnson W; Mela T;
    Heart Rhythm; 2016 Feb; 13(2):464-71. PubMed ID: 26409098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience.
    Seewöster T; Löbe S; Hilbert S; Bollmann A; Sommer P; Lindemann F; Bacevičius J; Schöne K; Richter S; Döring M; Paetsch I; Hindricks G; Jahnke C
    Europace; 2019 Aug; 21(8):1220-1228. PubMed ID: 31131393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Awad K; Griffin J; Crawford TC; Lane Cox S; Ferrick K; Mazur A; Pena RE; Lloyd SG; Michalski J; Johnson W; Bailey WM
    Heart Rhythm; 2015 Oct; 12(10):2155-61. PubMed ID: 26049048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Heart Rhythm Society and Canadian Association of Radiologists consensus statement on magnetic resonance imaging with cardiac implantable electronic devices.
    Verma A; Ha AC; Dennie C; Essebag V; Exner DV; Khan N; Lane C; Leipsic J; Philippon F; Sampaio M; Schieda N; Seifer C; Berthiaume A; Campbell D; Chakraborty S
    Can J Cardiol; 2014 Oct; 30(10):1131-41. PubMed ID: 25262858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Quality of 1.5-T MRI in Patients With Conventional and MRI-Conditional Cardiac Implantable Electronic Devices After Implementation of a Standardized Protocol.
    Camacho JC; Moreno CC; Shah AD; Mittal PK; Mengistu A; Lloyd MS; El-Chami MF; Lerakis S; Saindane AM
    AJR Am J Roentgenol; 2016 Sep; 207(3):599-604. PubMed ID: 27304515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.